Log in

RadNet Stock Forecast, Price & News

-0.46 (-3.07 %)
(As of 10/30/2020 12:00 AM ET)
Today's Range
Now: $14.51
50-Day Range
MA: $15.72
52-Week Range
Now: $14.51
Volume159,387 shs
Average Volume349,481 shs
Market Capitalization$748.35 million
P/E RatioN/A
Dividend YieldN/A
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems; and provides teleradiology services for remote interpretation of images on behalf of hospitals and hospital-based radiology groups. As of December 31, 2019, it operated 335 centers in California, Delaware, Florida, Maryland, New Jersey, and New York. RadNet, Inc. has a collaboration with Hologic, Inc. to advance the use of artificial intelligence in breast health. The company was founded in 1985 and is headquartered in Los Angeles, California.
Read More
RadNet logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.55 out of 5 stars

Industry, Sector and Symbol

Industry Medical laboratories
Current SymbolNASDAQ:RDNT



Sales & Book Value

Annual Sales$1.15 billion
Cash Flow$2.94 per share
Book Value$4.63 per share


Net Income$14.76 million


Market Cap$748.35 million
Next Earnings Date11/10/2020 (Estimated)
-0.46 (-3.07 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RDNT News and Ratings via Email

Sign-up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

RadNet (NASDAQ:RDNT) Frequently Asked Questions

How has RadNet's stock been impacted by COVID-19?

RadNet's stock was trading at $17.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RDNT stock has decreased by 15.7% and is now trading at $14.51.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of RadNet?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for RadNet

When is RadNet's next earnings date?

RadNet is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for RadNet

How were RadNet's earnings last quarter?

RadNet, Inc. (NASDAQ:RDNT) issued its earnings results on Monday, August, 10th. The medical research company reported ($0.16) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.44) by $0.28. The medical research company earned $190.60 million during the quarter, compared to analyst estimates of $190.58 million. RadNet had a negative net margin of 1.25% and a negative return on equity of 4.28%. The firm's quarterly revenue was down 34.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.12 EPS.
View RadNet's earnings history

What price target have analysts set for RDNT?

2 brokerages have issued 1 year price targets for RadNet's shares. Their forecasts range from $22.00 to $23.00. On average, they anticipate RadNet's stock price to reach $22.50 in the next twelve months. This suggests a possible upside of 55.1% from the stock's current price.
View analysts' price targets for RadNet

Who are some of RadNet's key competitors?

What other stocks do shareholders of RadNet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Opko Health (OPK), The Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T).

Who are RadNet's key executives?

RadNet's management team includes the following people:
  • Dr. Howard G. Berger, Chairman, Pres, CEO & Treasurer (Age 74, Pay $1.91M)
  • Mr. Mark D. Stolper, Exec. VP & CFO (Age 49, Pay $739.18k)
  • Mr. Norman R. Hames, Pres & COO of Western Operations (Age 64, Pay $803.5k)
  • Mr. Stephen M. Forthuber, Pres & COO of Eastern Operations (Age 59, Pay $814.56k)
  • Mr. Ranjan Jayanathan, Chief Information Officer & GM of eRAD - Radiology Information Technology Division
  • Ms. Laura Foster BSRT, MPH, J.D., Sr. VP of Compliance & Regulatory Affairs
  • Mr. David Jeffrey Katz, Exec. VP & Gen. Counsel (Age 56)
  • Ms. Ruth Louisa Wilson, Sr. VP of HR & Director (Age 56)
  • Dr. John V. Crues III, VP, Medical Director & Director (Age 70)
  • Mr. Michael M. Murdock, Exec. VP & Chief Devel. Officer (Age 65)

What is RadNet's stock symbol?

RadNet trades on the NASDAQ under the ticker symbol "RDNT."

Who are RadNet's major shareholders?

RadNet's stock is owned by a variety of retail and institutional investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (1.27%), Assenagon Asset Management S.A. (0.76%), Hennessy Advisors Inc. (0.25%), BNP Paribas Arbitrage SA (0.08%), Pacer Advisors Inc. (0.05%) and Keybank National Association OH (0.05%). Company insiders that own RadNet stock include B Kaplan Survivor's Tru Karen, David L Swartz, John V Crues, Mark Stolper, Michael L Md Sherman, Michael N Murdock and Norman R Hames.
View institutional ownership trends for RadNet

Which major investors are selling RadNet stock?

RDNT stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Cadence Capital Management LLC, and Hennessy Advisors Inc.. Company insiders that have sold RadNet company stock in the last year include John V Crues, and Norman R Hames.
View insider buying and selling activity for RadNet

Which major investors are buying RadNet stock?

RDNT stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Pacer Advisors Inc., Keybank National Association OH, BNP Paribas Arbitrage SA, and Louisiana State Employees Retirement System.
View insider buying and selling activity for RadNet

How do I buy shares of RadNet?

Shares of RDNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is RadNet's stock price today?

One share of RDNT stock can currently be purchased for approximately $14.51.

How big of a company is RadNet?

RadNet has a market capitalization of $748.35 million and generates $1.15 billion in revenue each year. The medical research company earns $14.76 million in net income (profit) each year or $0.29 on an earnings per share basis. RadNet employs 6,165 workers across the globe.

What is RadNet's official website?

The official website for RadNet is www.radnet.com.

How can I contact RadNet?

RadNet's mailing address is 1510 COTNER AVE, LOS ANGELES CA, 90025. The medical research company can be reached via phone at 310-478-7808 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.